Dinci Pennap

US Food and Drug Administration

Poster(s):

• (41) Α-1 Adrenergic Receptor Antagonists and Risk of Severe COVID-19
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (86) Impact of Angiotensin-Receptor-Blocker (ARB) Recalls Due to Nitrosamine Contamination on ARB Utilization in The U.S., Canada, and Denmark
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (290) Risk of Intentional Self Harm and Suicide Among 5-Alpha Reductase Inhibitor Users and Alpha-Blocker Users
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (21) Suicide Poisoning Mortality: A Comparison of The National Poison Control Center and CDC National Datasets
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST